Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | HPN | P05981 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.48 |
| ▸ | KDR | P35968 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2471777 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP3A4HSD17B10TSHRALOX15 | |
| SCHEMBL29383145 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP3A4HSD17B10TSHRALOX15 | |
| SCHEMBL12168748 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP3A4HSD17B10TSHRALOX15 | |
| SCHEMBL29644944 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP3A4HSD17B10TSHRALOX15 | |
| SCHEMBL29366399 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP3A4HSD17B10TSHRALOX15 | |
| SCHEMBL29469562 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP3A4HSD17B10TSHRALOX15 | |
| SCHEMBL19113839 | 0.91 | TSHR (0.43) | ALDH1A1CYP3A4HSD17B10TSHRALOX15 | |
| SCHEMBL13821762 | 0.87 | ALDH1A1 (0.42) | ALDH1A1CYP3A4HSD17B10TSHRALOX15 | |
| SCHEMBL14507604 | 0.87 | CYP3A4 (0.40) | ALDH1A1CYP3A4HSD17B10TSHRALOX15 | |
| SCHEMBL13894504 | 0.87 | ALDH1A1 (0.40) | ALDH1A1CYP3A4HSD17B10TSHRALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4580489-A1 | DEVICES AND METHODS FOR MEASURING A CONCENTRATION OF A TARGET ANALYTE IN A BIOLOGICAL FLUID IN VIVO | DexCom, Inc. (US) | 2025-07-09 | — | — | EP | claimed |
| WO-2024050124-A1 | DEVICES AND METHODS FOR MEASURING A CONCENTRATION OF A TARGET ANALYTE IN A BIOLOGICAL FLUID IN VIVO | DEXCOM, INC. (US) | 2024-03-07 | — | — | WO | claimed |
| US-20240074682-A1 | DEVICES AND METHODS FOR MEASURING A CONCENTRATION OF A TARGET ANALYTE IN A BIOLOGICAL FLUID IN VIVO | DEXCOM, INC. (US) | 2024-03-07 | — | — | US | claimed |
| US-20220249411-A1 | CALIXARENE COMPOUNDS AND USES THEREOF | Universität Wien (AT) | 2022-08-11 | — | — | US | claimed |
| EP-4633804-A1 | PROCESS FOR PREPARING ALPHA,BETA-UNSATURATED CARBONYL COMPOUND | Firmenich SA (CH) | 2025-10-22 | — | — | EP | disclosed |
| EP-4580489-A1 | DEVICES AND METHODS FOR MEASURING A CONCENTRATION OF A TARGET ANALYTE IN A BIOLOGICAL FLUID IN VIVO | DexCom, Inc. (US) | 2025-07-09 | — | — | EP | disclosed |
| EP-4531681-A1 | SYSTEMS AND METHODS FOR OPTIMIZING TREATMENT USING PHYSIOLOGICAL PROFILES | Dexcom, Inc. (US) | 2025-04-09 | — | — | EP | disclosed |
| EP-4531680-A1 | SENSING SYSTEMS AND METHODS FOR DIAGNOSING KIDNEY DISEASE | Dexcom, Inc. (US) | 2025-04-09 | — | — | EP | disclosed |
| EP-4531679-A1 | SYSTEMS AND METHODS FOR MONITORING, DIAGNOSIS, AND DECISION SUPPORT FOR DIABETES IN PATIENTS WITH KIDNEY DISEASE | Dexcom, Inc. (US) | 2025-04-09 | — | — | EP | disclosed |
| EP-4482383-A1 | SENSING SYSTEMS AND METHODS FOR PROVIDING DECISION SUPPORT AROUND KIDNEY HEALTH AND/OR DIABETES | Dexcom, Inc. (US) | 2025-01-01 | — | — | EP | disclosed |
| WO-2024126769-A1 | PROCESS FOR PREPARING ALPHA,BETA-UNSATURATED CARBONYL COMPOUND | FIRMENICH SA (CH) | 2024-06-20 | — | — | WO | disclosed |
| EP-3119610-B1 | ENCRYPTED OPTICAL MARKERS FOR SECURITY APPLICATIONS | APDN BVI INC (VG) | 2024-05-22 | — | — | EP | disclosed |
| WO-2009078371-A2 | PROCESS FOR PRODUCING CARBON MATERIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-06-25 | — | — | WO | disclosed |
| US-7282083-B2 | Methods, systems, and uses for calixarenes | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-10-16 | — | — | US | disclosed |
| US-20070215839-A1 | Molecular actuators, and methods of use thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2007-09-20 | — | — | US | disclosed |
| US-7271259-B1 | Solid phase host compositions | NORTHWESTERN UNIVERSITY (US) | 2007-09-18 | — | — | US | disclosed |
| US-20050063861-A1 | Methods, systems, and uses for calixarenes | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2005-03-24 | — | — | US | disclosed |
| WO-2004056708-A1 | MATERIAL FOR THE REMOVAL OF POLLUTANTS | UNIVERSITY OF SURREY (GB) | 2004-07-08 | — | — | WO | disclosed |
| US-5641684-A | Ion-sensitive dyes | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1997-06-24 | — | — | US | disclosed |
| EP-0572599-A1 | ION-SENSITIVE DYES | KODAK LIMITED (GB) | 1993-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070215839-A1 | Molecular actuators, and methods of use thereof | NOD2, PIEZO1, TPR | ALDH1A1 4481/4885CYP3A4 2410/4885HSD17B10 4759/4885 |
| US-20220249411-A1 | CALIXARENE COMPOUNDS AND USES THEREOF | GPX1, LPO, CALR | ALDH1A1 259/4885CYP3A4 1632/4885HSD17B10 804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.